Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1981-11-22
|
pubmed:abstractText |
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age- and sex-matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well-documented cholinergic derangement in Alzheimer disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0364-5134
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
122-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7283399-Aged,
pubmed-meshheading:7283399-Alzheimer Disease,
pubmed-meshheading:7283399-Basal Ganglia,
pubmed-meshheading:7283399-Cell Count,
pubmed-meshheading:7283399-Cholinergic Fibers,
pubmed-meshheading:7283399-Dementia,
pubmed-meshheading:7283399-Humans,
pubmed-meshheading:7283399-Male
|
pubmed:year |
1981
|
pubmed:articleTitle |
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.
|
pubmed:publicationType |
Journal Article,
Case Reports
|